Search
for
Sort by
Research 301–330 of 309
- Valproic acid monotherapy induced longitudinal melanonychia
- Rumpel-Leede Phenomenon Associated with Pneumatic Compression: A Case Report
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- A 15-Year-Old Girl with Trichorhinophalangeal Syndrome Type 1 with Non-ossifying Fibroma in Femur: A Case Report
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Myxedema Coma and Acute Hepatopathy in a Dog with Severe Atherosclerosis
- Stem Cell Therapy for Burns: Story so Far
- Growth hormone deficiency with late-onset hypothalamic hypoadrenocorticism associated with respiratory and renal dysfunction: a case report
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Cutaneous adverse effects of targeted therapies
- Nilotinib-Induced Keratosis Pilaris
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The PDGF/PDGFR pathway as a drug target
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Cutaneous drug reactions
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress